Exelixis (EXEL) Company Profile: FKnol.com

U.S. Stock Screener:

Exelixis has the following business profile:

Business Profile of Exelixis (EXEL)
Company's Full Name:	Exelixis, Inc.
Short Name:	Exelixis
Trading Ticker Symbol:	EXEL
Primary Exchange:	NASDAQ
Headquarter City/Country:	California, CA
Primary Industry Sector:	Healthcare
Secondary Sub-sector:	Members Only! Login / Register to view
Tertiary Sub-sector:	Members Only! Login / Register to view
Main Business Areas/Categories:	Members Only! Login / Register to view
Dividend Payments:	Dividend History
ETFs Holding:	List of ETFs holding Exelixis stock

Market and Trading Information for Exelixis

The following details were available for trading and market data about the stock of Exelixis as of writing:

Trading Details of Exelixis (EXEL)
Current Share Price:	$22.7
Previous Year's Closing Price:	$23.99
Percentage Price Change (YTD):	-5.38%
Market Cap:	$6.92 billion
52-week Price Range:	$18.08 - $24.34
Dividend Per Share:	$0
EPS (TTM):	0.65
Price-Earnings (Trailing):	34.92
Price-Earnings (Forward):	15.55

Company Profile and Business Description for Exelixis

Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. Its cabozantinib product is an inhibitor of multiple tyrosine kinases, inc...to see full details, please Login / Register to view.

ETFs Holding Exelixis Stock

As of March 2020, the following exchange-traded funds (ETF) hold the Exelixis stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Exelixis stock holding. There are a total of 79 ETFs in Fknol.com records which are holding Exelixis stock in their portfolio. See Full List.

Ticker	Name	Short Description	Expense Ratio	No. of Holdings	Dividend Frequency
AFMC	First Trust Active Factor Mid Cap ETF	AFMC is an actively managed portfolio of factor-focused US midcap companies seeking capital appreciation. ...Full Details	0.65%	207 Full List
AIEQ	AI Powered Equity ETF	The AI Powered Equity ETF is an actively managed fund of US stocks selected by a proprietary, quantitative model that incorporates artificial intelligence (AI). ...Full Details	0.75%	108 Full List	Quarterly
AVUS	Avantis US Equity ETF	AVUS is an actively managed diverse portfolio of U.S. large-, mid-, and small-cap stocks aiming to find those with lower price relative to valuations. ...Full Details	0.15%	1856 Full List
BBP	Virtus LifeSci Biotech Products ETF	The Virtus LifeSci Biotech Products ETF tracks an index of biotechnology companies considered to be in the "product stage" by the index provider. ...Full Details	0.79%	43 Full List	Annually
BUL	Pacer US Cash Cows Growth ETF	BUL tracks a fundamental-selected and -weighted index of U.S. growth equities. ...Full Details	0.6%	52 Full List	Annually
CFA	VictoryShares US 500 Volatility Weighted Index ETF	The VictoryShares US 500 Volatility Wtd Index Fund tracks an index of the largest US stocks by market cap, screened for positive earnings and weighted by volatility. ...Full Details	0.35%	501 Full List	Monthly
CFO	VictoryShares US 500 Enhanced Volatility Weighted ETF	The VictoryShares US 500 Enhanced Volatility Wtd Index ETF tracks an index of the largest US stocks by market cap, screened for positive earnings and weighted by volatility. The fund can move to 75% cash maximum in market downturns. ...Full Details	0.35%	501 Full List	Monthly
COWZ	Pacer US Cash Cows 100 ETF	The Pacer US Cash Cows 100 ETF tracks an index of companies selected from the Russell 1000 Index and weighted accord to their free cash flow. ...Full Details	0.49%	101 Full List	Quarterly
EQAL	Invesco Russell 1000 Equal Weight ETF	The Invesco Russell 1000 Equal Weight Index Portfolio tracks an index of the 1000 largest US stocks. Each sector receives equal weight, and each stock within a sector receives equal weight. ...Full Details	0.2%	971 Full List	Quarterly
ESGV	Vanguard ESG US Stock ETF	The Vanguard ESG U.S. Stock ETF tracks a market-cap-weighted index of US companies screened for environmental, social, and corporate governance (ESG) criteria. ...Full Details	0.12%	988 Full List	Quarterly

See Full List of ETFs holding Exelixis stock in their respective portfolios.

U.S. Stock Screener:

Peer / Competitor Companies of Biotech-Commercial Physical Biological Research Sector

Along with Exelixis, Inc., the following other peer (competitor) companies also exist within the same Biotech-Commercial Physical Biological Research - Healthcare sector whose company profile and dividend history is as follows:

▶ Anavex Life Sciences (AVXL): Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and ....See Detailed Company Profile, Dividend History

▶ Bioanalytical (BASI): Bioanalytical systems, Inc., incorporated on July 17, 1975, is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers ....See Detailed Company Profile, Dividend History

▶ Charles River Laboratories International (CRL): Charles River Laboratories International, Inc., incorporated on February 3, 1994, is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and ....See Detailed Company Profile, Dividend History

▶ Cleveland BioLabs (CBLI): Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. ....See Detailed Company Profile, Dividend History

▶ Exact Sciences (EXAS): Exact Sciences Corporation, incorporated on February 10, 1995, is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. The Company offers ....See Detailed Company Profile, Dividend History

▶ ICON (ICLR): ICON public limited company, incorporated on May 31, 1989, is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device ....See Detailed Company Profile, Dividend History

▶ Incyte (INCY): Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ....See Detailed Company Profile, Dividend History

▶ Intrexon (XON): Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ....See Detailed Company Profile, Dividend History

▶ Luna Innovations (LUNA): Luna Innovations Incorporated, incorporated on April 4, 2003, develops, manufactures and markets fiber optic sensing and test, and measurement products. The Company is focused on bringing technology solutions to measure ....See Detailed Company Profile, Dividend History

▶ Medpace (MEDP): Medpace Holdings, Inc., incorporated on February 18, 2014, is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, ....See Detailed Company Profile, Dividend History

▶ NanoViricides (NNVC): NanoViricides, Inc., incorporated on April 1, 2005, is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its ....See Detailed Company Profile, Dividend History

▶ Pieris Pharma (PIRS): Pieris Pharmaceuticals, Inc., incorporated on May 24, 2013, is a clinical-stage biopharmaceutical company. The Companys pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled ....See Detailed Company Profile, Dividend History

▶ PRA Health Sciences (PRAH): PRA Health Sciences, Inc., incorporated on June 21, 2013, is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company ....See Detailed Company Profile, Dividend History

▶ Sorrento Therapeutics (SRNE): Sorrento Therapeutics, Inc., incorporated on December 4, 2009, is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus ....See Detailed Company Profile, Dividend History

▶ Tenax Therapeutics (TENX): Tenax Therapeutics, Inc., incorporated on April 17, 2008, is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Companys ....See Detailed Company Profile, Dividend History

... See Full List of All Stocks of Biotech-Commercial Physical Biological Research Sector.